TheProfitWatch

RNXT - RenovoRx, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.8 0.0 (-0.19%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.63%) -0.02 (-2.69%) 0.01 (0.81%) -0.02 (-3.06%) 0.0 (-0.08%)

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.08
Diluted EPS:
-0.08
Basic P/E:
-9.98
Diluted P/E:
-9.98
RSI(14) 1m:
47.45
VWAP:
0.8
RVol:

Events

Period Kind Movement Occurred At

Related News